Systemic Interleukin-1β stimulates the simultaneous release of norepinephrine in the paraventricular nucleus and the median eminence

Interleukin-1beta (IL-1beta), a cytokine with pronounced central effects such as fever, anorexia, analgesia, etc., is also known to activate the hypothalamo-pituitary-adrenal (HPA) axis. Corticotropin releasing hormone (CRH) neurons located in the hypothalamus are important for HPA activation. The cell bodies of CRH neurons are located in the paraventricular nucleus (PVN) and their terminals are present in the median eminence (ME). Although the catecholamines, norepinephrine (NE) and dopamine (DA) are believed to be crucial factors in the stimulation of CRH neurons, it is not clear if they affect the cell bodies or terminals of these neurons to cause HPA activation. This study was done to determine if IL-1beta affects NE and DA release at the level of CRH cell bodies or their terminals. Adult male Sprague-Dawley rats were implanted with two push-pull cannulae, one in the PVN and another in the ME, and were subjected to push-pull perfusion. They were treated either with 0, 1 or 5 microg of IL-1beta. Perfusates were collected for 2 h after treatment and analyzed for NE concentrations using HPLC-EC. NE levels in the control and low dose groups did not change significantly during the entire period of observation both in the PVN and ME. In contrast, treatment with 5 microg of IL-1beta produced a marked increase in NE release in the PVN at 20 and 40 min post-treatment. NE release in the ME increased from 10 to 140 min post-treatment. There were no significant changes in the release of DA from both these areas. These results indicate that IL-1beta increases NE levels both in the PVN and in the ME and this could be a possible mechanism by which it stimulates the HPA axis.

[1]  K. Grove,et al.  Distribution of corticotropin releasing hormone receptor immunoreactivity in the rat hypothalamus: coexpression in neuropeptide Y and dopamine neurons in the arcuate nucleus , 2003, Brain Research.

[2]  H. Watanobe,et al.  Effects of intravenous administration of interleukin-1-beta on the release of prostaglandin E2, corticotropin-releasing factor, and arginine vasopressin in several hypothalamic areas of freely moving rats: estimation by push-pull perfusion. , 1994, Neuroendocrinology.

[3]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[4]  J. Watt,et al.  Interleukin‐1β immunoreactivity in identified neurons of the rat magnocellular neurosecretory system: Evidence for activity‐dependent release , 2000, Journal of neuroscience research.

[5]  P. MohanKumar,et al.  Systemic administration of interleukin-1 stimulates norepinephrine release in the paraventricular nucleus. , 1993, Life sciences.

[6]  A. Blomqvist,et al.  Rat brain vascular distribution of interleukin‐1 type‐1 receptor immunoreactivity: Relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli , 2004, The Journal of comparative neurology.

[7]  P. MohanKumar,et al.  Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from the hypothalamus in vivo. , 1991, Life sciences.

[8]  R. Murison,et al.  Effect of central noradrenaline depletion on corticosterone levels and gastric ulcerations in rats , 1986, Brain Research.

[9]  H. Ovadia,et al.  Selective facilitation of putative corticotropin-releasing factor-secreting neurones by interleukin-1 , 1990, Neuroscience Letters.

[10]  A. Dunn,et al.  The role of cerebral noradrenergic systems in the Fos response to interleukin-1 , 1996, Brain Research Bulletin.

[11]  Y. Ishizuka,et al.  Effects of area postrema lesion and abdominal vagotomy on interleukin-1β-induced norepinephrine release in the hypothalamic paraventricular nucleus region in the rat , 1997, Neuroscience Letters.

[12]  S. Leibowitz,et al.  Norepinephrine in the paraventricular nucleus stimulates corticosterone release , 1989, Brain Research.

[13]  C. Dinarello,et al.  The biological properties of interleukin-1. , 1994, European cytokine network.

[14]  P. MohanKumar,et al.  Correlations of catecholamine release in the medial preoptic area with proestrous surges of luteinizing hormone and prolactin: effects of aging. , 1994, Endocrinology.

[15]  Y. Pollak,et al.  Administration of interleukin-1 into the hypothalamic paraventricular nucleus induces febrile and behavioral effects. , 1997, Neuroimmunomodulation.

[16]  Y. Ishizuka,et al.  Fos expression in neurons immunoreactive for neuronal nitric oxide synthase in the rat paraventricular nucleus after intraperitoneal injection of interleukin-1β , 2000, Neuroscience Research.

[17]  C. Dayas,et al.  Descending pathways from the paraventricular nucleus contribute to the recruitment of brainstem nuclei following a systemic immune challenge , 2003, Neuroscience.

[18]  S. Matta,et al.  The adrenocorticotropin response to interleukin-1 beta instilled into the rat median eminence depends on the local release of catecholamines. , 1990, Endocrinology.

[19]  P. MohanKumar,et al.  Interleukin-1β increases 5-hydroxyindoleacetic acid release in the hypothalamus in vivo , 1993, Brain Research Bulletin.

[20]  W. Vale,et al.  Stimulatory effect of interleukin-1 on adrenocorticotropin secretion in the rat: is it modulated by prostaglandins? , 1991, Endocrinology.

[21]  I. Assenmacher,et al.  Different responses of plasma ACTH and corticosterone and of plasma interleukin‐1β to single and recurrent endotoxin challenges , 1996, Journal of leukocyte biology.

[22]  S. Gaillet,et al.  Lesions of the afferent catecholaminergic pathways inhibit the temporal activation of the CRH and POMC gene expression and ACTH release induced by human interleukin-1beta in the male rat. , 1995, Neuroendocrinology.

[23]  P. Sawchenko,et al.  Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus , 1988, The Journal of comparative neurology.

[24]  S. Chiocchio,et al.  Sympathetic innervation of the median eminence , 1984, Brain Research.

[25]  I. Wakabayashi,et al.  Interleukin-1beta administered intracerebroventricularly stimulates the release of noradrenaline in the hypothalamic paraventricular nucleus via prostaglandin in the rat. , 1998, Endocrine journal.

[26]  M. Palkovits,et al.  Noradrenergic innervation of the rat hypothalamus: Experimental biochemical and electron microscopic studies , 1980, Brain Research.

[27]  S. MohanKumar,et al.  Specificity of interleukin–1β-induced changes in monoamine concentrations in hypothalamic nuclei: blockade by interleukin-1 receptor antagonist1 1 Dedicated to the memory of Dr. S. K. Quadri, a distinguished scientist and an inspiring teacher. , 1998, Brain Research Bulletin.

[28]  R. de Waal Malefyt,et al.  Biological properties of interleukin 10. , 1992, Immunology today.

[29]  H. Watanobe,et al.  Intrahypothalamic perfusion with interleukin-1-beta stimulates the local release of corticotropin-releasing hormone and arginine vasopressin and the plasma adrenocorticotropin in freely moving rats: a comparative perfusion of the paraventricular nucleus and the median eminence. , 1993, Neuroendocrinology.

[30]  S. Gaillet,et al.  Complex catecholaminergic modulation of the stimulatory effect of interleukin-1β on the corticotropic axis , 1993, Brain Research.

[31]  H. Yang,et al.  Evidence for hypothalamic paraventricular nucleus as an integrative center of neuroimmunomodulation. , 1997, Neuroimmunomodulation.

[32]  A. Ferguson,et al.  Interleukin‐1β Depolarizes Paraventricular Nucleus Parvocellular Neurones , 2003 .

[33]  S. Gaillet,et al.  Effects of discrete lesions in the ventral noradrenergic ascending bundle on the corticotropic stress response depend on the site of the lesion and on the plasma levels of adrenal steroids. , 1993, Neuroendocrinology.